Follow Forum_Psych on Twitter

Display results as :

Rechercher Advanced Search

We have 222 registered users
The newest registered user is raheelmemon

Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.

Efficacy Among Second-Generation Antidepressants is About the Same

Go down

Efficacy Among Second-Generation Antidepressants is About the Same

Post  Admin on Sat Jan 28, 2012 2:46 pm

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder.
Ann Intern Med. 2011 Dec 6;155(11):772-85.

Second-generation antidepressants dominate the management of major depressive disorder (MDD),
but evidence on the comparative benefits and harms of these agents is contradictory.

Meta-analyses and mixed-treatment comparisons of response to treatment and weighted mean differences were conducted on specific scales to rate depression.

- No clinically relevant differences in efficacy or effectiveness were detected for the treatment of acute, continuation, and maintenance phases of MDD.
- No differences in efficacy were seen in patients with accompanying symptoms or in subgroups based on age, sex, ethnicity, or comorbid conditions.
- Individual drugs differed in onset of action, adverse events, and some measures of health related quality of life.

Current evidence does not warrant recommending a particular second-generation antidepressant on the basis of differences in efficacy. Differences in onset of action and adverse events may be considered when choosing a medication.

Full article (PDF) is available here:

Click on to post your comments

Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia

Back to top Go down

Back to top

- Similar topics

Permissions in this forum:
You cannot reply to topics in this forum